Quick Answer
Denali Therapeutics Inc. reported Shares Outstanding of 156.18 million shares for fiscal year 2025.
Denali Therapeutics Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 156.18M | +8.3% |
| 2024 | 144.22M | +4.2% |
| 2023 | 138.39M | +1.8% |
| 2022 | 135.97M | +11.2% |
| 2021 | 122.28M | +1.5% |
| 2020 | 120.53M | +25.3% |
| 2019 | 96.19M | +1.6% |
| 2018 | 94.66M | +8.2% |
| 2017 | 87.48M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 146.63M | +1.9% | +0.6% |
| June 30, 2025 | 145.69M | +1.8% | +0.3% |
| March 31, 2025 | 145.25M | +1.9% | +0.7% |
| December 31, 2024 | 144.22M | +4.2% | +0.3% |
| September 30, 2024 | 143.84M | +4.2% | +0.5% |
| June 30, 2024 | 143.12M | +4.2% | +0.4% |
| March 31, 2024 | 142.51M | +4.2% | +3.0% |
| December 31, 2023 | 138.39M | +1.8% | +0.2% |
- Denali Therapeutics Inc. showed an increase of +8.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Denali Therapeutics Inc.’s shares outstanding has grown by 78.5% (from 87.48 million shares to 156.18 million shares).
- The most recent figure is from Denali Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: